The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study-Reference-Cited by-同舟云学术

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study

Published:2011-08-09 Issue:4 Volume:54 Page:1208-1216
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bhala Neeraj,Angulo Paul,van der Poorten David,Lee Eric,Hui Jason M.,Saracco Giorgio,Adams Leon A.,Charatcharoenwitthaya Phunchai,Topping Joanne H.,Bugianesi Elisabetta,Day Christopher P.,George Jacob

Publisher

Wiley

Subject

Hepatology

Reference31 articles.

1. Epidemiology and natural history of non-alcoholic steatohepatitis;Argo;Clin Liver Dis,2009

2. GI epidemiology: nonalcoholic fatty liver disease;Angulo;Aliment Pharmacol Ther,2007

3. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

4. Non-alcoholic fatty liver disease;Bhala;BMJ,2009

5. Non-alcoholic fatty liver disease: current concepts and management strategies;Day;Clin Med,2006

Cited by 403 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population;Clinics and Research in Hepatology and Gastroenterology;2024-08

3. Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study;Alimentary Pharmacology & Therapeutics;2024-07-22

4. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression;United European Gastroenterology Journal;2024-06-18

5. Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD;Hepatology Communications;2024-06